Kardiodex AS
Score · fiscal year 2025
Not enough data: Revenue not reported
Based on the annual accounts for 2025
The numbers behind the score
| Measure | Company | Median |
|---|---|---|
| Operating margin | – | 5.7% |
| Profit margin | – | 5.6% |
| Return on assets | −4.2% | 13.3% |
| Equity ratio | 100.0% | 41.8% |
| Debt-to-equity | – | 1.11 |
| Current ratio | – | 1.50 |
| Revenue growth | – | 4.0% |
The median and “ahead of” refer to companies in the same sector in 2025. The bar shows the share of companies the figure is ahead of.
Score over time
Score over time needs at least two fiscal years with a score. It will appear when next year's figures are fetched or history is imported.
The industry or the company: what drove the result?
The company and its sector's drivers
Prices, rate and currency that shape the sector's year, year by year beside the operating margin of Kardiodex AS. The figures stand side by side; we claim no cause.
Consumer price index (indeks (2025 = 100))
| Measure | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Consumer price index, annual average | 84.3 | 89.2 | 94.1 | 97.0 | 100.0 | 102.9 (so far) |
| Change from the year before | +3.5% | +5.8% | +5.5% | +3.2% | +3.0% | +2.9% |
| The company's operating margin | – | – | – | – | – | – |
Source: SSB (14710, CC BY 4.0). Source
Policy rate (prosent)
| Measure | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Policy rate, annual average | 0.08 | 1.32 | 3.54 | 4.50 | 4.30 | 4.17 (so far) |
| Change from the year before | −0.28 percentage points | +1.24 percentage points | +2.22 percentage points | +0.96 percentage points | −0.20 percentage points | −0.12 percentage points |
| The company's operating margin | – | – | – | – | – | – |
Source: Norges Bank (IR, NLOD 2.0). Source
Wage index: health services (indeks)
| Measure | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Wage index: health services, annual average | 88.0 | 91.6 | 96.0 | 100.6 | 105.8 | 109.5 (so far) |
| Change from the year before | +2.5% | +4.1% | +4.7% | +4.9% | +5.1% | +3.6% |
| The company's operating margin | – | – | – | – | – | – |
Source: SSB (12314, CC BY 4.0). Source
We show the drivers and the margin side by side and claim no cause. Sensitivity per company is not computed until we have at least 10 years of accounts per company: with three years such figures are false precision.
What the numbers say
Kardiodex AS had an equity ratio of 100.0% in 2025. The company is not ranked: revenue not reported.
No large changes in the key figures from 2024 to 2025.
This text is generated automatically from the 2025 accounts.
Three simple methods
One method gives a figure: 0 MNOK.
| Method | Multiple | Estimate |
|---|---|---|
| P/E | 20.3 | not meaningful |
| EV/EBIT | 20.7 | not meaningful |
| P/B | 1.3 | 0 MNOK |
The listed basis is the value at listed multiples. The estimate is lowered by 51% for an unlisted company: 20% for lack of marketability and 38% for size (a small-company premium of 4% on the cost of equity).
A mechanical estimate from public accounts, not advice. A mechanical estimate from public accounts with listed multiples and fixed adjustments. Not a valuation and not advice to buy or sell. See the calculation
Worth a closer look
- watch
The company made a loss before tax. Are these one-off items or a pattern?
Based on: Profit margin – (median 5.6%).
Indications based on the latest annual accounts from open data. Not investment or financial advice.
See interest rates, prices and exchange rates for the sector
Data quality
- watch Revenue not reported
Scenario analysis: the sector's weakest year
We have no accounts for 2026, the sector's weakest year, for this company.
The sector's weakest year was 2026, with a median operating margin of −10.4%. Based on the 6 fiscal years we have. The analysis grows as more years are fetched or imported. Methodology
Questions and answers
How profitable is Kardiodex AS?
The operating margin was – in 2025, against a median of 5.7% among companies in the same sector. Return on assets was −4.2%. The company made a loss before tax.
How solid is Kardiodex AS?
The equity ratio was 100.0% in 2025 (median 41.8%).
From the Central Coordinating Register
- Org. no.
- 916858744
- Legal form
- AS
- Sector
- Helse og omsorg (86.993)
- Employees
- 0–4 (not registered)
- Founded
- 3 March 2016 10 years in operation
- Share capital
- 0.20 MNOK
- Business address
- c/o Sebastian Jentschke, Leilighet H0302, Fløenbakken 41C, 5009 BERGEN
- Municipality
- Bergen rank 8 of 11 in KOSTRA group 12
- Audit
- Audit opted out from 18 March 2016
- Latest accounts filed
- 2025
Source: Central Coordinating Register, Brønnøysund Register Centre. The employee count is reported by the company and may be older than the accounts. See the company at the Brønnøysund Register Centre
Ownership and roles
Loading roles …
Source: Central Coordinating Register, fetched 2 November 2026. Only names are shown.
Shareholders (2025)
- Number of shareholders
- 2
- Largest owner
- 50.0%
- Split
- companies 0% · private persons 100% · foreign 0%
- Owned from the same municipality
- 100%
The company is new in the shareholder register in 2025.
Source: the Norwegian Tax Administration's shareholder register as of 2025. Figures may be older than today's ownership. Private persons are not shown by name.
Error in the data?
Do you see an error in the figures or in how the company is mapped (sector, holding, group)? Let us know. Corrections require documentation.
Figures last fetched 31 October 2026.
Year by year · 2023–2025
| Key figure | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|
| Index | – | – | – | |
| Rank | – | – | – | |
| Operating margin | – | – | – | |
| Return on assets | −4.4% | −3.7% | −4.2% | |
| Equity ratio | 100.0% | 100.0% | 100.0% | |
| Current ratio | – | – | – | |
| Revenue growth | – | – | – |
Accounts
From the Brønnøysund Register Centre, in the company's reporting currency (NOK).
| Key figure | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating revenue | – | – | – |
| Operating profit | 0.0 MNOK | 0.0 MNOK | 0.0 MNOK |
| Profit before tax | 0.0 MNOK | 0.0 MNOK | 0.0 MNOK |
| Tax expense | – | – | – |
| Net profit | 0.0 MNOK | 0.0 MNOK | 0.0 MNOK |
| Financial expenses | – | – | 0.0 MNOK |
| Total assets | 0.1 MNOK | 0.1 MNOK | 0.1 MNOK |
| Current assets | 0.0 MNOK | 0.0 MNOK | 0.0 MNOK |
| Equity | 0.1 MNOK | 0.1 MNOK | 0.1 MNOK |
| Retained earnings | −0.1 MNOK | −0.1 MNOK | −0.1 MNOK |
| Total liabilities | 0.0 MNOK | 0.0 MNOK | – |
| Current liabilities | – | – | – |
Source: Brønnøysund Register Centre (Register of Company Accounts), fetched 31 October 2026, accounts id 6711840.